Gene Query: CHRDL1

Dataset Description Geneva Score
Global transcriptome analysis of HAP1 cells 117.49
Genetic disruption of COX-1 inhibits multiple oncogenic pathways 109.72
GATA3-mediated chromatin reprogramming in breast cancer cells 108.69
FOXP1 orchestration of ASD-relevant signaling pathways. 104.02
Next Generation Sequencing Facilitates Quantitative Analysis of human patient derived primary Glioblastoma (GBM) cancer cell Transcriptomes 98.01
STRIPAK directs PP2A activity to promote oncogenic transformation 97.06
RNA sequencing of BT142 and TS603 cell lines 86.02
Metabolic Reprogramming Associated with Aggressiveness Occurs in the G-CIMP-High Molecular Subtypes of IDH1mut Lower Grade Gliomas 86.02
RNA-seq in untreated and flagellin-treated Human Intestinal Myofibroblast cells (HIMF) 74.71
KLF6-dependent transcription in renal cancer cells 70.81
Effect of 48h treatment with 100nM GSK2879552 on T-ALL cell lines LOUCY and PEER 68.45
Human induced pluripotent stem cell-derived vocal fold mucosa mimics development and responses to smoke exposure 57.7
Comparing gene expression in iPSC derived RPE from control and AMD donors 57.15
Bi-allelic Alteration and Dysregulation of the Hippo Pathway in Mucinous Tubular and Spindle Cell Carcinoma of the Kidney 53.32
A SIRT1-centered Circuitry Regulates Breast Cancer Stemness and Metastasis 53.01
Role of COP1 on MAP kinase transcriptional output in melanoma 52.64
A High-Throughput Screen Identifies DYRK inhibitor ID-8 that Stimulates Human Kidney Tubular Proliferation 51.85
RNA-seq of human aneuploid cell lines with Trisomy 21 49.41
Transcription elongation factors are in vivo-specific cancer dependencies in glioma 47.56
RNA-seq Profiles in Transcription elongation factors are in vivo-specific cancer dependencies in glioma 47.56
Osteogenic programming of adipose-derived mesenchymal stem cells using a fungal metabolite that suppresses the Polycomb protein EZH2 47.0
mRNA Profiling of miR-17 family inhibition using TuD lentiviral vector in HepG2 and SK-Hep1 hepatocellular carcinoma cell lines [RNA-Seq] 45.45
Lipid Nanoparticle-Mediated Delivery of Anti-miR-17 Family Oligonucleotide Suppresses Hepatocellular Carcinoma Growth 45.45
RNA-seq analysis of CRISPR/Cas9 generated human BMPR2 deficient endothelial cell lines harboring mutations characteristic for hereditary pulmonary hypertension (HPAH) 45.36
Heterogeneous effects of massive hypoxia pathway activation in kidney cancer 45.2
Morphological and molecular characterization of human dermal lymphatic collectors 41.72
RNA-seq data from human SGBS adipocytes differentiated with marine oxohexadecenoic acids 41.19
Cancer avatars derived from genetically engineered pluripotent stem cells allow for longitudinal assessment of tumor development 36.0
Patient iPSC-Derived Neurons for Disease Modeling of Frontotemporal Dementia with Mutation in CHMP2B 35.95
Gene expression profile in FTSEC cells (FT190 and FT194 cell lines) transduced with shRNA to knockdown RNF20 or with control shRNA using RNA-seq. 35.93
FTSEC cells (FT190 and FT194 cell lines) transduced with shRNA to knockdown RNF20 or with control shRNA 35.93
Exercise-induced transcriptome changes in skeletal muscle adapted to aerobic training 33.11
ARID2 promotes clear cell renal cell carcinoma in the absence of functional PBRM1 [RNA-seq] 32.93
ARID2 promotes clear cell renal cell carcinoma in the absence of functional PBRM1 32.93
In vivo genome editing restores dystrophin expression in Duchenne muscular dystrophy patient muscle fibers 32.64
SMUG1 promotes telomere maintenance through telomerase RNA end-processing 32.23
GDF6-induced BMP signaling reawakens a neural crest identity in melanoma to prevent cell death and differentiation 31.42
Differential gene expression of human melanoma cells [RNA-seq] 31.42
RNA-seq reveals changes in the astrocyte transcriptome following Borrelia burgdorferi infection 30.98
microRNA-seq and RNA-seq reveals changes in the astrocyte transcriptome following Borrelia burgdorferi infection 30.98
High throughput analysis of three human adipose cell lines PAZ6, SGBS and SW872 30.85
Comprehensive analysis of microRNA expression in regionalized human neural progenitor cells reveals microRNA-10 as a caudalizing factor 29.7
The effect of PPARG inhibition on human angiomyolipoma cells 29.62
Gene expression profiling via RNA sequencing of patient brain tumors cultured in 3D bioengineered cultures 29.05
RNAseq data from SCCOHT1 and OVCAR8 ovarian cancer cells treated with BET inhibitors 28.74
Targeting MYC dependency in ovarian cancer through inhibition of CDK7 and CDK12/13 27.57
RNA-Seq in two Ewing sarcoma cell lines: A673 and SKNMC 27.4
Identification of Resistance Genes to BRAF Inhibitor in Melanoma by piggyBac Transposon Activation Mutagenesis Screen 27.27
Molecular analysis of high-grade serous ovarian carcinoma with and without associated serous tubal intra-epithelial carcinoma [RNA-Seq; normal samples] 26.66
Role of CD133 molecule in WNT response and renal repair 25.73
Preliminary Report of Transplantation of Human Fetal Retinal Pigment Epithelial Cells on Age-related Macular Degeneration Patients 25.68
Gene expression changes upon drug withdrawal (A375/451Lu cell lines) 24.93
RNA-seq of tumor cells following angiopellosis extravasation 24.45
RNA-seq and Microarray in Transcriptome Profiling of Anterior Cruciate Ligament Tears: Implications for Prognostic Biomarkers Discovery 23.91
Human Long Intergenic Noncoding RNA Linc-ADAL Knockdown in Mature Adipocytes using Lentiviral ShRNA 23.74
Generation of mature lung alveolar epithelial cells from human pluripotent stem cells 23.3
Effect of disulfiram treatment on pediatric high grade glioma 23.29
RNA seq_A375 gSMARCB1 + A549 etoposide, Aurora kinases inhibitors treated 22.41
Spontaneous single-copy loss of TP53 in human embryonic stem cells markedly increases cell proliferation and survival [RNA-Seq] 22.38
Spontaneous single-copy loss of TP53 in human embryonic stem cells markedly increases cell proliferation and survival 22.38
RNA-seq of SOX5 overexpressing primary human neuronal progenitors 22.37
RNA expression in primary huamn muscle cells treated with 1,25(OH)2D3 or vehicle 21.78
mRNA and miRNA expression in primary human muscle cells treated with 1,25(OH)2D3 or vehicle 21.78
Diverse and Targetable Kinase Alterations Drive Histiocytic Neoplasms 21.72
Integrated analysis of MLL-AF9 AML patients and model leukemias highlights RET and other novel therapeutic targets (RNA-seq B-ALL) 21.37
Chromatin landscape of human visceral and subcutaneous adipocytes 21.33
The expression profiles of GBC liver metastasis 20.97
OBESITY IS ASSOCIATED WITH IMPAIRED EXPRESSION OF THE GLYCOSYLTRANSFERASE EOGT IN DECIDUALIZING ENDOMETRIUM 20.63
RNA-Seq of Kaposi’s sarcoma reveal alterations in glucose and lipid metabolism 20.22
Modeling human brain evolution using induced pluripotent stem cells: comparative analysis of neuronal development in humans and chimpanzees 20.07
Combined Experimental and System-Level Analyses Reveal the Complex Regulatory Network of miR-124 during Human Neurogenesis [d7+d14] 19.79
Transcriptome of invasive mucinous adnocarcinoma of the lung and adjacent normal lung tissues from 6 patients based on RNA-seq method 19.71
Identification of metabolically distinct adipocyte progenitor cells in human adipose tissues 19.1
Cranial pericytes derived from neural crest cells reveal an inherent cell type-specific defect in Alzheimer's Disease 19.09
Human iPSC derived glomeruli facilitate accurate modelling of podocytopathy 18.96
Transcriptomic hallmarks of tumor plasticity and stromal interactions in brain metastasis [MultiDisease] 18.75
Ebola virus (EBOV) infection of ARPE-19 cells 18.6
Adaptation of the Kinome Promotes Resistance to BET Bromodomain Inhibitors in Ovarian Cancer 18.56
Transcriptomic hallmarks of tumor plasticity and stromal interactions in brain metastasis 18.37
Total RNA sequencing of prospective axial stem cell cultures derived from human pluripotant stem cells 18.03
Gene expression changes in human melanoma cell lines compared to primary melanocytes 17.53
PAK4 suppresses RELB to prevent senescence-like growth arrest in breast cancer 17.29
Transcriptional analysis of ZIKV-infected Ifnar-/- and Ifnar+/- placentas and IFN-beta (IFN-b) or IFN-lambda (IFN-l) treated human mid-gestation chorionic villus explants 17.15
Analysis of transcriptional differences after IFN-beta (IFN-b) or IFN-lambda (IFN-l) treated human mid-gestation chorionic villus explants 17.15
Long non-coding RNA expression profile associated with malignant progression of oral submucous fibrosis 17.0
Global reduction in H3K27me3 and DNA hypomethylation define poorly prognostic pediatric posterior fossa ependymomas 16.81
Expression data from human perivascular stem cell-derived extracellular vesicles (PSC-EVs) and PSCs 16.66
Defective removal of ribonucleotides from DNA promotes systemic autoimmunity 16.66
Coordination of neuron production in mouse and human cerebral cortex by the homolog of Drosophila Mastermind protein 16.63
RNA-seq and flow-cytometry of conventional, scalp, and palmoplantar psoriasis reveal shared and distinct molecular pathways 16.56
CD95L derived si- and shRNAs kill cancer cells through an RNAi mechanism by targeting survival genes [shL3.shR6.RNAseq.lg] 16.45
RNA-seq melanoma 16.28
Transcriptome profiling of influenza virus-infected human bronchial epithelial cells 16.2
POLR3G Dependent PolyA+ and smallRNA Transcriptomes in Human Pluripotent Stem Cells 16.15
De novo reconstruction of human adipose reveals conserved lncRNAs as regulators of brown adipogenesis 16.13
Neural cell adhesion molecule 1 (NCAM1; CD56) promotes leukemogenesis and confers drug resistance in acute myeloid leukemia. 15.75
Effect of the knockdown of MLL1 and MLL2 on pediatric high grade glioma 15.51
Compared performance of Affymetrix HTA arrays and Illumina RNAseq for the analysis of tumours [RNA-seq] 15.51
Compared performance of Affymetrix HTA arrays and Illumina RNAseq for the analysis of tumours 15.51
Differential YAP expression in glioma cells induces cell competition and promotes tumorigenesis 15.42
An acquired vulnerability of drug resistant melanoma with therapeutic potential 15.27
RNA Seq data: A375, A375R, A375DR vorinostat treated, and biopy samples from patients pre- and post- treated with Vorinostat 15.27
Regionally specified human pluripotent stem cell-derived astrocytes 14.8
Patient iPSC-derived neural stem cells display progressive enlargement of lysosomes and disruptions of glycosaminoglycan pathway and autophagy in concordance with clinical severity of Mucopolysaccharidosis I 14.31
mRNAseq of Huntington's disease and control patient iPSC-derived neural cells 14.27
Transcriptomic and Epigenomic analysis of Huntington's disease and control patient iPSC-derived neural cells 14.27
Identifying a novel candidate diagnostic and prognostic biomarker SPRR3 for oral squamous cell carcinoma via mRNA Sequencing and Bioinformatics 13.9
SIRT7 Antagonizes TGF-β Signaling and Inhibits Breast Cancer Metastasis 13.62
Gene expression profile of LMSU gastric cancer cell p53 KO and KD 13.61
The gene expression profiles of gallbladder cancer 13.61
RNA deep sequencing analysis of glioma stem cells(GSCs) and non-GSCs 13.52
Endometrial epithelial cell transcriptome response to co-culture with adipose stromal cells 13.45
PTEN interacts with the transcription machinery on chromatin and regulates RNA polymerase II-mediated transcription.[RNA-seq and ChIP-seq] 13.44
PTEN interacts with the transcription machinery on chromatin and regulates RNA polymerase II-mediated transcription 13.44
Functional astrocytes differentiated from hiPSCs 13.34
Epigenomic landscape during organ formation in human early embryos 13.3
Obstructed defecation – an enteric neuropathy? An exploratory study of patient samples 13.02
Single-cell Transcriptomic Atlas of the Human Retina Identifies Cell Types Associated with Age-Related Macular Degeneration 12.74
Integrated Profiling of mRNAs and microRNAs to Identify Potential Biomarkers for Oral Malignant Transformation 12.54
Integrated Profiling of mRNAs and microRNAs to Identify Potential Biomarkers for Oral Malignant Transformation [mRNA-Seq] 12.54
The cohesin release factor WAPL restricts chromatin loop extension. [RNA-Seq] 12.04
The cohesin release factor WAPL restricts chromatin loop extension. 12.04
Endogenous interaction profiling identifies DDX5 as an oncogenic coactivator of transcription factor Fra-1 11.79
Endogenous interaction profiling identifies DDX5 as an oncogenic coactivator of transcription factor Fra-1 [RNA-seq] 11.79
Single cell transcriptome of peritoneal cells 11.77
IKZF1 as a Master Regulator of Immune Infiltrate Recruitment in Solid Tumors 11.7
Identifying markers predicting successful graft outcome for clinical translation of hESC-based cell therapy for Parkinson’s disease 11.69
Transcriptional profiling of MDA-MB-231 and its ρ0 cells (lacking mtDNA) after 48h arginine depletion by arginine deiminase (ADI). 11.63
RNA sequencing for PDX1, NGN3 and MAFA transduced iPSCs cell 11.49
Differential gene expression analysis between proliferating and quiescent human dermal fibroblasts 11.41
Epigenetic Control of Skeletal Development by the Histone Methyltransferase Ezh2 11.4
ASCL1 mediates neuronal differentiation of primary GBM stem cell cultures upon Notch signalling blockade [RNA-seq] 11.08
A practical evaluation of alignment algorithms for RNA variant calling analysis 11.01
Impact of HypERrlnc Knockdown on the human pericyte transcriptome 10.85
TRIM24 is an oncogenic transcriptional co-activator of STAT3 in glioblastoma 10.78
Circular RNAs are super abundant in cervical tumor and plasma detected by high throughput microarray [RNA-Seq] 10.77
Circular RNAs are super abundant in cervical tumor and plasma detected by high throughput microarray 10.77
BMS-470539 on human synovial fibroblasts 10.42
Chronophin regulates metabolic and transcriptomic features of glioblastoma stem-like cells 10.42
Transcriptome profiles of moderate dysplasia in oral mucosa associated with malignant conversion 10.38
Transcriptome analysis of diverse cell types infected with human cytomegalovirus [RNA-Seq] 10.33
Mitochondrial 3243A > G mutation confers pro-atherogenic and pro-inflammatory properties in MELAS iPS derived endothelial cells 10.2
a-synuclein accumulation in an iPSC derived model of early onset sporadic Parkinson’s Disease reveals novel drug targets 10.16
Spatial proximity to fibroblasts impacts molecular features and therapeutic sensitivity of breast cancer cells influencing clinical outcomes 10.1
Mutational landscape of splicing genes and functional consequences across 33 cancer types 9.64
Impaired DNA damage metabolism promotes autoimmunity in TREX1 deficiency  9.63
Fibroblasts in cholesteatoma activate osteoclasts. 9.6
RNA Sequencing Analysis of villus tissues from unexplained recurrent spontaneous abortion patients and controls with induced abortions 9.6
Maturing an Enteric Nervous System in Human Intestinal Organoid-derived Tissue-Engineered Small Intestine 9.43
Reconstruction of the Human Blood-Brain Barrier in vitro reveals a Pathogenic Mechanism of APOE4 in Pericytes 9.24
Profiling gene expression changes in primary ovarian tumors compared to matched normal fallopian tubes 9.23
Integration of genome-wide DNA methylome and transcriptome of human intestinal fibroblasts reveals novel candidate gene signatures in Crohn’s disease-associated fibrosis 8.93
Generation of induced keratinocyte stem cells from human urine cells by defined transcription factors 8.83
Novel kinase fusion oncogenes in post-Chernobyl radiation-induced pediatric thyroid cancers 8.76
RNA-seq of UGP2 mutant human embryonic stem cells and in vitro differentiated neural stem cells 8.68
Pericyte-like cells generated from human pluripotent stem cells support hematopoietic stem and progenitors ex vivo 8.51
S-adenosyl-methionine treatment selectively block liver cancer cell lines transformation and invasiveness by alterations of cancer- and invasion specific transcriptome and methylome 8.49
S-adenosyl-methionine treatment selectively block liver cancer cell lines transformation and invasiveness by alterations of cancer- and invasion specific transcriptome and methylome (RNA-Seq) 8.49
Myeloid-derived suppressor cells facilitie invasion and metastasis of papillary thyroid cancer cells by repressing miR-486-3p 8.41
Improving fibroblast characterization using single-cell RNA sequencing: an optimized tissue disaggregation and data processing pipeline 8.34
Transcriptomic profile of human embryonic renal corpuscles 8.28
Concomitant BCORL1 and BRAF mutations in vemurafenib-resistant melanoma cells 8.23
Triplet nucleotide repeat-based siRNAs are highly toxic to cancer cells 8.23
RNA sequencing of prostate cancer and normal tissue from African Americans and European Americans 8.21
Widespread regulated alternative splicing of single codons accelerates proteome evolution 8.21
RNA-seq analysis of control and CDK12-depleted ovarian cancer cells 8.18
Total RNA sequencing of APC mutant and wt colonic organoids 8.09
Transcriptomic analysis of human neural progenitor cells differentiation into astrocytes 8.08
Novel Targeting of Transcription and Metabolism in Glioblastoma 7.86
Expression profiling by high throughput sequencing of tumors derived from human prostate epithelial cells transformed with the oncogenes N-Myc and myrAKT1. 7.85
Transcriptome of melanoma cell lines resistant to inhibition of the MAPK pathway. 7.8
CD95L derived si- and shRNAs and the CD95L mRNA kill cancer cells through an RNAi mechanism by targeting survival genes [siL3.RNAseq.lg] 7.8
Non-coding and coding transcriptional profiles are significantly altered in pediatric Retinoblastoma tumors 7.7
Gene expression profile of human iPSC-derived nephron progenitor cells 7.65
Treatment Paradigms for Retinal and Macular Diseases Using 3-D Retina Cultures Derived From Human Reporter Pluripotent Stem Cell Lines 7.46
Genes regulated by SPDEF or FOXA3 in A549 lung carcinoma cells [RNA-seq] 7.41
Molecular analysis of renal cell carcinoma with unclassfied histology 7.38
Molecular analysis of renal cell carcinoma with unclassfied histology [gene expression] 7.38
Inducible three-factor direct reprogramming to nephron progenitors using piggyBac transposons 7.33
Gene expression of thyroid cancer cell lines 7.32
Polysome-associated mRNA profiling of cancer cells in response to CXCL12 and IGF1 7.31
Identification of differentially expressed circRNA in gallbladder cancer compared with matched normal tissue 7.28
The histone H3.3K27M mutation in pediatric glioma reprograms H3K27 methylation and gene expression 7.22
SHP2 Drives Adaptive Resistance to ERK Signaling Inhibition in Molecularly Defined Subsets of ERK-dependent Tumors 7.19
Inherent DNA binding specificities of the HIF-1α and HIF-2α transcription factors in chromatin 7.17
Inherent DNA binding specificities of the HIF-1α and HIF-2α transcription factors in chromatin (RNA-seq) 7.17
Long noncoding RNA LNMAT1 promotes lymphatic metastasis in bladder cancer 7.15
Whole genome analysis of the methylome and hydroxymethylome in normal and malignant lung and liver 7.11
Whole genome analysis of the methylome and hydroxymethylome in normal and malignant lung and liver [RNA-Seq] 7.11
mRNA-sequencing of breast cancer subtypes and normal tissue 7.1
Nickel induced transcriptional changes persist post exposure through epigenetic reprograming (RNA-seq dataset) 6.99
Gene expression profile of HGC27 and LMSU gastric cancer cell p53 KO and KD 6.99
Assessing placental maturity through histological and transcriptomic analyses in idiopathic spontaneous preterm birth 6.98
ZRANB2 and SYF2 mediated splicing programs converging on ECT2 are involved in breast cancer cell resistance to doxorubicin 6.92
Select correlative genes involved in pathogenesis of idiopathic interstitial pneumonia by high-throughput sequencing analysis 6.73
Gene expression profiling of papillary thyroid cancer from central and invasive regions 6.73
Mapping cis-regulatory chromatin contacts in neural cells links neuropsychiatric disorder risk variants to target genes 6.72
Mapping cis-regulatory chromatin contacts in neural cells links neuropsychiatric disorder risk variants to target genes [RNA-Seq] 6.72
Genome-wide expression analysis of human hTert immortalized fibroblasts after downregulation of MCM2 6.67
An aspartyl protease defines a novel pathway for export of Toxoplasma proteins into the host cell 6.64
Browning of human adipocytes requires KLF11 and reprogramming of PPARγ super-enhancers 6.63
Transcriptome of iPSC-derived Cerebral Organoids with Heterozygous Knockout in CHD8 6.52
Single Cell Analysis Reveals Unexpected Transcriptional Heterogeneity of Neural Progenitors in the Developing Human Cortex 6.39
FOXP2's impact on the primate transcriptome 6.36
Two dimensional and extracellular matrix based three-dimensional cultures of lung and breast cancer cells 6.31
Gene expression profiling in two dimensional and extracellular matrix based three-dimensional cultures of lung and breast cancer cells 6.31
‘Naïve’ ESRRB+ iPSCs with the capacity for rapid neural differentiation 6.3
Generation of induced neural stem cells from urine derived cells by synthetic mRNA 6.29
Reciprocal Reprogramming of Cancer Cells and Associated Mesenchymal Stem Cells in Gastric Cancer. 6.26
Ascorbate Suppresses VEGF Expression in Retinal Pigment Epithelial Cells 6.25
Comparative Transcriptomics of Triple Negative Breast Cancer Stem Cells and Differentiated Tumor Cells Identifies Teneurin-4 as a Potential Therapeutic Target 6.23
Locally transplanted human urine-induced nephron progenitor cells contribute to renal repair in mice kidney with diabetic nephropathy 6.23
Transcriptome analysis of virus infected tissues 6.18
Reducing the structure bias of RNA-Seq reveals a large number of non-annotated non-coding RNA 6.17
AUF-1 affected genes in human skin cells 6.11
Elucidating the microRNA-203 specific biological processes in glioblastoma cells from comprehensive high-throughput RNA-sequencing transcriptome profiling 6.02
Neuronal Development And The Onset Of Electrical Activity In The Human Enteric Nervous System 5.98
High level DNA repair gene expression in human ES cells 5.85
Effect of digoxin treatment on the gene and alternative splice expression in human pluripotent stem cells- derived mesenchymal stem cells 5.8
RNA sequence analysis of stable versus reversible EMT events and the resultant metastases 5.78
Aneuploidy-induced cellular stresses limit autophagic degradation. 5.71
MUC1-C represses the RASSF1A tumor suppressor and activated Kras signaling in human carcinoma cells 5.7
Paired Related Homeobox Protein 1 Regulates Quiescence in Human Oligodendrocyte Progenitors 5.63
Generation of Patient-Matched Malignant and Normal Primary Cell Cultures from Clear Cell Renal Cell Carcinoma Patients 5.57
RNA sequencing and pathway analysis identify important pathways involved in hypertrichosis and intellectual disability in patients with Wiedemann-Steiner syndrome 5.56
RNA-seq analysis reveals profound changes in transcript profiles between siCon- and siH19-transfected EVT cells 5.53
The Wnt/β-catenin-signaling pathway is modulated by androgen ablation therapy for advanced clinical prostate cancer and contributes to androgen independent cell growth 5.5
Next Generation Sequencing identifying the dosage compensation state in human endometrial carcinoma and adjacent tissues 5.49
RNA sequencing of T-ALL (COG study) 5.45
Analyses of T-ALL (COG study) 5.45
Methylome, hydroxymethylome, and integrative transcriptome profiling in human CRC tissue and paired normal tissues 5.41
Gene expression analysis of a panel of human fibroblasts that generate an aligned (anisotropic) vs non-aligned extracellular matrix 5.36
CAR T cell trogocytosis and cooperative killing regulate tumour antigen escape 5.33
Next Generation Sequencing of Transcriptomes of Cutaneous Melanocytes and Metastatic Melanoma Cell Lines (mRNA-Seq) 5.24
Next Generation Sequencing of Transcriptomes of Cutaneous Melanocytes and Metastatic Melanoma Cell Lines 5.24
transcriptome studies of BRD4 inhibitor BDF-1253 on renal clear carcinoma 786-O cells 5.21
A Unique Epigenomic Landscape Defines Human Erythropoiesis 5.19
A Unique Epigenomic Landscape Defines Human Erythropoiesis (RNA-seq) 5.19
Transcriptome sequencing of differentially expressed genes in mouse and human skin with and without NCSTN mutation 5.16
Transcriptome sequencing of differentially expressed genes in acne inversa (AI) patients with NCSTN mutation and healthy individuals 5.16
Transcript abundance in A-T-derived iPSC: Comparing isogenic cells to unrelated individual 5.12
HLA peptides derived from tumor antigens induced by inhibition of DNA methylation for development of drug-facilitated immunotherapy 5.11
RNA sequencing of MDA-MB231 and U2OS cancer cell lines exposed to the alkylating agent methyl methanesufonate (MMS) and classical chemotherapeutics  5.1
Activity-dependent transcriptional changes in human neurons 5.04
Gene expression profile in breast cancer cell lines using RNA sequencing 5.04
iPSC-Derived Cholangiocytes 5.03
Characterizing the Chemoresistant Ovarian Cancer Population using the Heterogeneous PDX 5.02
Che-1 is targeted by c-Myc to sustain proliferation in pre-B-cell acute lymphoblastic leukemia 4.91
Che-1 is targeted by c-Myc to sustain proliferation in pre-B-cell acute lymphoblastic leukemia [RNA-seq] 4.91
A Surveillance System of Active Enhancers by a RACK7-histone Demethylase Complex 4.91
CHD1 regulates cell fate determination by activation of differentiation-induced genes 4.89
Identification of the role of polydom in neurofibromas 4.89
Single-cell transcriptomic analysis of tissue resident memory T cells in human lung cancer [ 10x genomics] 4.86
Effects of human adipose tissue-derived and umbilical cord tissue-derived mesenchymal stem cells in a dextran sulfate sodium-induced mouse model 4.81
Transcriptomics profiles of patient-matched normal kidney and ccRCC pairs 4.77
Deletion of DXZ4 on the human inactive X chromosome eliminates superdomains and impairs gene silencing 4.74
Identification of alternatively spliced transcripts in brain metastatic derivatives of MDA-MB-231 breast cancer cells in response to RBM47 expression 4.73
The identification of RBM47 binding sites and RBM47-dependent alternative splicing events in brain metastatic breast cancer cells 4.73
Integrative analysis of mRNA and lncRNA profiles identified pathogenetic lncRNAs in esophageal squamous cell carcinoma 4.73
Toxoplasma gondii infection of human retinal pigment epithelial cells 4.72
NSD2 overexpression links drives clustered chromatin and transcriptional changes in a subset of insulated domains of insulated domains 4.64
A genomic study of the contribution of DNA methylation to regulatory evolution in primates 4.6
Profiling in vivo Bone Lesion (IVBL) and Orthotopic tumors by Next Generation Sequencing 4.6
Deciphering H3K4me3 Broad Domains Associated With Gene Regulatory Networks and Conserved Epigenomic Landscapes in the Human Brain [RNA-Seq] 4.56
Deciphering H3K4me3 Broad Domains Associated With Gene Regulatory Networks and Conserved Epigenomic Landscapes in the Human Brain 4.56
Expression changes in melanoma cell lines pre MAPKi treatment vs. post-MAPKi resistance (RNA-seq_CellLine.batch2) 4.53
Essential Roles of SETD7 as Transcriptional Activator and Co-regulator of H3K36me in Cardiac Lineage Commitment 4.48
iPSC derived motor neuron cultures from C9ORF72 carriers 4.44
Next Generation Sequencing Facilitates Quantitative Analysis of Retinoblastoma Transcriptomes 4.42
Adaptive chromatin remodeling in glioblastoma stem cell plasticity and drug tolerance 4.33
Transcriptome of human white and brown adipose tissue biopsies 4.33
Gene expression profiling of patient's DCIS-IDC tandem lesions by RNA sequencing analysis 4.29
Normal stroma suppresses cancer cell proliferation via mechanosensitive regulation of JMJD1a-mediated transcription [RNA-Seq] 4.27
Normal stroma suppresses cancer cell proliferation via mechanosensitive regulation of JMJD1a-mediated transcription 4.27
Identification and validation of differentially expressed transcripts by RNA-Sequencing of formalin-fixed, paraffin-embedded (FFPE) lung tissue from patients with Idiopathic Pulmonary Fibrosis 4.24
Next Generation Sequencing Facilitates Comparisons of Control and Schizophrenia-Patient derived hiPSC-derived neurons 4.23
RNA-sequencing of milk cells extracted from pre-partum secretions and longitudinally from mature human milk across the first year of lactation 4.22
Identification of transcripts altered upon LIN-41 knockdown in human embryonic stem cells 4.22
6mer seed toxicity in viral microRNAs 4.21
Single cell analysis of smooth muscle cell phenotypic modulation in vivo during disease in mice and humans [human scRNA-seq] 4.21
Single cell analysis of smooth muscle cell phenotypic modulation in vivo during disease in mice and humans 4.21
Wnt5a and its downstream transcription factor Stat3 are therapeutic targets for diffuse intrinsic pontine gliomas 4.18
Transcriptional profile of human STAT1-/- fibroblasts expressing LY6E or empty control vector 4.17
Mllt3 Governs Self-Renewal And Engraftment Of Human Hematopoietic Stem Cells 4.16
RNA-seq of MLLT3-overexpressing cultued HSPC, compared to non-overexpressing and uncutured FL-HSPC [RNAseq_MLLT3_OE] 4.16
Expression profiling by RNA-Seq of breast cancer samples from patients in walnut-consuming and control groups 4.15
Sequencing of matched pair samples (diagnosis and relapse) in human B-cell acute lymphoblastic leukemia cells (ALL) 4.07
Metformin induces chromosome reorganization and changes in gene expression in normal human fibroblasts 4.03
Effect of Hotair overexpression in human breast cancer cell lines 4.02
Reversing Abnormal Neural Development by Inhibiting OLIG2 in Down Syndrome Human iPSC Brain Organoids and Neuronal Mouse Chimeras 4.01
Receptor tyrosine kinase signaling promotes post-embryonic morphogenesis and survival of glia and neural progenitor cells 3.99
Gene expression profiling of human iPS cell-derived podocytes and sorted human adult podocytes 3.98
Convergent roles of ATF3 and CSL in chromatin control of CAF activation 3.97
Convergent roles of ATF3 and CSL in chromatin control of CAF activation [RNA-seq] 3.97
Next Generation Sequencing Analysis of Colorectal Cancer Tissue Transcriptomes 3.91
Low MITF/AXL ratio predicts early resistance to multiple targeted drugs in melanoma 3.86
Neuronal deletion of Gtf2i, associated with Williams syndrome, causes behavioural and myelin alterations rescuable by a remyelinating drug [human] 3.84
Neuronal deletion of Gtf2i, associated with Williams syndrome, causes behavioural and myelin alterations rescuable by a remyelinating drug 3.84
Next generation sequencing of advanced non-castrate prostate cancer treated with docetaxel chemotherapy 3.83
Dynamic developmental signaling logic underlying lineage bifurcations during human endoderm induction and patterning from pluripotent stem cells 3.79
Dynamic developmental signaling logic underlying lineage bifurcations during human endoderm induction and patterning from pluripotent stem cells [Endoderm RNA-seq and ChIP-seq data sets] 3.79
Genomic and proteomic resolution of heterochromatin and its restriction of alternate fate genes 3.77
Genomic and proteomic resolution of heterochromatin and its restriction of alternate fate genes (RNA-seq) 3.77
Hydrogel scaffolds promote neural gene expression and structural reorganization in human astrocyte cultures 3.72
Verification and rectification of cell type-specific splicing of a Seckel syndrome-associated ATR mutation using iPS cell model 3.71
A Surveillance System of Active Enhancers by a RACK7-histone Demethylase Complex (RNA-Seq I) 3.68
Human germ cell formation in xenotransplants of induced pluripotent stem cells carrying X chromosome aneuploidies 3.65
Transcriptional differences between skin from patients with atopic dermatitis and control skin obtained from the healthy margins of Mohs surgery patients 3.63
Genome-wide detection of DNase I hypersensitive sites in single cells and FFPE tissue samples 3.55
Age-Related Gene Expression Changes in Prostate Cancer Patients 3.53
Age-Related Gene Expression Changes in Prostate Cancer Patients [RNA-Seq] 3.53
Global transcriptional changes in U87MG glioblastoma cells upon shRNA-mediated TRIM52 knockdown 3.5
Systematic Functional Perturbations Uncover a Prognostic Genetic Network Driving Human Breast Cancer [RNA-Seq] 3.5
Systematic Functional Perturbations Uncover a Prognostic Genetic Network Driving Human Breast Cancer 3.5
An Open-Label Pilot Study to Evaluate the Efficacy of Tofacitinib in Moderate to Severe Patch Type Alopecia Areata, Totalis and Universalis 3.49
The Polycomb protein BMI1 induces an invasive gene expression signature in melanoma that promotes metastasis and chemoresistance. 3.44
Gene expression analysis of ER+ and ER- breast cancer cell lines with acquired resistance to palbociclib 3.38
Necroptosis inhibition protects from dopaminergic neuronal cell death in OPA1 mutant Parkinson’s disease patient neurons and MPTP treated mice 3.37
Self-organized amniogenesis by human pluripotent stem cells in a biomimetic implantation-like niche 3.36
The lipodystrophic hotspot lamin A p.R482W mutation deregulates the mesodermal inducer T/Brachyury and early vascular differentiation gene networks 3.36
Gata6 potently initiates reprogramming of pluripotent and differentiated cells to extraembryonic endoderm stem cells 3.31
Gata6 potently initiates reprogramming of pluripotent and differentiated cells to extraembryonic endoderm stem cells [ChIP-Seq & RNA-Seq] 3.31
RNA-seq analysis of hPSC-derived brain pericyte-like cells, hPSC-derived neural crest stem cells, and primary human brain pericytes 3.29
Engineered human pluripotent stem cell-derived intestinal tissues with a functional enteric nervous system 3.2
Human-specific gene ARHGAP11B promotes basal progenitor amplification and neocortex expansion 3.2
Respecifying human iPSC-derived blood cells into highly engraftable hematopoietic stem and progenitor cells with a single factor 3.19
Mesenchymal stem/stromal cell engulfment reveals metastatic advantage in breast cancer 3.16
Transcriptome of iPSC-derived Neural Cells with Heterozygous Knockout in CHD8 3.08
RNA-Seq analysis of HIF-2a-responsive genes in clear-cell renal cell carcinoma 3.08
RNA sequencing Facilitates Quantitative Analysis of luminal breast cancer cells and basal breast cancer cells Transcriptomes 3.07
Epigenomic conservation of transposable element silencing 3.01
Epigenomic conservation of transposable element silencing [RNA-seq] 3.01
Transcriptomic analyssis following EHMT1/2 inhibition 2.98
Differential expression of genes in HCMV-infected fibroblasts regulated by the purinergic receptor P2Y2. 2.95
Regulation of hypoxia-inducible factor activity by ZMYND8 2.93
Hyper-excitability of Neurons generated from Patients with Bipolar Disorder 2.92
TrapSeq: An RNA Sequencing-based pipeline for the identification of genetrap insertions in mammalian cells 2.91
Profile of gene expression in U87-MG xenografts expressing control vector (V0), the ubiquitin ligase KPC1 or the p50 subunit of the NF-kB transcription factor, using RNASeq analysis of transcripts mapped independently to the human and murine genomes 2.9
Gene expression profile difference among renal location in a stone former 2.87
LncRNA NONHSAT113026 represses renal cell carcinoma tumorigenesis through interacting with NF-κB/p50 and SLUG 2.87
RNA Expression Profile of Calcified Bicuspid, Tricuspid and Normal Human Aortic Valves by RNA Sequencing [TAV] 2.86
Total RNA sequencing of WT intestinal orgaonids. 2.86
Modulation of ESRP2 and MBNL2 in normal kidney and clear cell renal cell carcinoma cell lines for analysis of stability programs 2.84
Single Cell RNA-sequencing of cell types isolated by FACS from normal human prostates 2.84
Altered Hydroxymethylation is seen at regulatory regions in pancreatic cancer and regulates oncogenic pathways [RNA-seq] 2.83
Altered Hydroxymethylation is seen at regulatory regions in pancreatic cancer and regulates oncogenic pathways 2.83
Hepatosplenic T cell lymphoma 2.78
Integrative Genomic and Transcriptomic Analysis Identified Candidate Genes Implicated in the Pathogenesis of Hepatosplenic T-cell Lymphoma 2.78
Identification of long noncoding RNAs in T-ALL cell lines 2.77
Transcriptional profiling identifies differential expression of long non-coding RNAs in Jo-1 associated and inclusion body myositis 2.71
Prospective Isolation and Comparison of Human Germinal Matrix and Glioblastoma EGFR+ Populations with Stem Cell Properties 2.68
Generation of low passage high grade serous ovarian cancer cell lines from primary tumors 2.67
Short-term effect of Boost versus Radical doses of Intraoperative electron Radiotherapy in breast cancer tumor bed using high-throughput approaches 2.66
A specific missense mutation in GTF2I occurs at high frequency in thymic epithelial tumors 2.63
Gene-Edited Human Kidney Organoids Reveal Mechanisms of Disease in Podocyte Development 2.58
RNA sequencing of prostate cancers reveal insights on the prognostic significance of visibility on multi-parametric MRI 2.55
Flura-seq identifies organ-specific adaptations in metastasis-initiating cells 2.55
Differential gene expressions in the heart of hypertrophic cardiomyopathy patients 2.54
Transcriptome Analysis and Functional Identification of Adipose-Derived Mesenchymal Stem Cells in Secondary Lymphedema 2.53
H3K36 mutations promote sarcomagenesis through genome-wide remodeling of H3K36 and H3K27 methylation [RNA_Chondroblastoma_H3K36M_H3WT] 2.52
H3K36 mutations promote sarcomagenesis through genome-wide remodeling of H3K36 and H3K27 methylation 2.52
Effects of transcription on genome - nuclear lamina interactions: RNA-seq data 2.49
Effects of transcription on genome - nuclear lamina interactions 2.49
Transcriptome profiling of the interconnection of pathways involved in malignant transformation and response to hypoxia 2.49
Transcriptome data of temporal and cingulate cortex in the Rett syndrome brain 2.48
Gene expression of collecting duct carcinoma of the kidney 2.47
Effect of SF3B1 suppression in cancer cells with different SF3B1 copy-number levels 2.46
Generation, transcriptome profiling, and functional validation of cone-enriched human retinal organoids 2.42
Transcriptomic analysis to underly the heterogeneity between 4 cellular models derived from patients diagnosed with pediatric high-grade gliomas under controlled atmosphere (modulation of oxygen level). 2.38
Transcriptional study of ARN8 cells treated with novel DHODH inhibitors 2.32
Single-Cell Transcriptome Analysis of Lineage Diversity and Microenvironment in High-Grade Glioma 2.32
Defective transcription elongation in a subset of cancers confers immunotherapy resistance (BGI12 RNA-Seq) 2.29
Dynamics of MBD2 deposition across methylated DNA regions during malignant transformation of human mammary epithelial cells (2) 2.25
Dynamics of MBD2 deposition across methylated DNA regions during malignant transformation of human mammary epithelial cells 2.25
Medial Ganglionic Eminence and Cortical Organoids Model Human Brain Development and Interneuron Migration [RNA-seq2] 2.25
Patient-derived xenograft platform for metastatic melanoma: a model for studying resistance to targeted therapy. 2.24
Gene expression profiles in HMC3 cells after exposure to ketamine or its active metabolites: 2R6R-HNK and 2S6S-HNK 2.24
Exogenous rescue of KLHL9 in SF210 cell line 2.23
A transcriptome-wide divergence in protein translation scales with LIN28B expression 2.22
Unlocking the transcriptomic potential of formalin-fixed paraffin embedded clinical tissues: Comparison of gene expression profiling approaches [RNA-Seq] 2.21
Unlocking the transcriptomic potential of formalin-fixed paraffin embedded clinical tissues: Comparison of gene expression profiling approaches 2.21
Human stem cell based models of neuronal migration provide insight into neurological disease pathogenesis and potential treatment 2.19
KLF4 as a rheostat of osteolysis and osteogenesis in prostate tumors in the bone 2.15
LINE-2 transposable elements are a source of functional human microRNAs and target sites 2.14
Investigation about fibroblasts of different origins in culture 2.11
RNA-seq data of adipocytes co-cocultured with OVCAR5 in Boyden chamber (4d) 2.11
Identification of altered developmental pathways in human juvenile HD iPSC with 71Q and 109Q using transcriptome profiling 2.1
Single Cell RNASeq profiling of stromal vascular fraction from Subcutaneous and visceral adipose tissue 2.09
Profiling and bioinformatics analyses reveal differential expression of circular RNA in tongue cancer revealed by high-throughput sequencing 2.09
Derivation of ventrical and atrial cardiomyocytes and maturation using biowires 2.09
Identification of Tissue-Specific Protein-Coding and Noncoding Transcripts across 14 Human Tissues Using RNA-seq 2.03
RNA-Seq analysis of proliferating 4N and 2N RPE1 cells derived from single cell clones following inhibition of Aurora B to induce polyploidization [tpo10] 2.02
Cockayne syndrome A and B proteins regulate the transcription arrest upon genotoxic stress through a ubiquitin/proteasome degradation process (RNA-seq) 1.91
Cockayne syndrome A and B proteins regulate the transcription arrest upon genotoxic stress through a ubiquitin/proteasome degradation process 1.91
Novel Atherogenic Pathways from the Differential Transcriptiome Analysis of Diabetic Epicardial Adipose Tissue 1.88
The SS18-SSX fusion oncoprotein hijacks BAF complex targeting and function to drive synovial sarcoma [RNA-Seq Tumor] 1.87
Gene expression profiles of active and restricted R/G-HIV+ primary human fetal astrocytes 1.85
Molecular Pathology of adverse local tissue reaction caused by metal-on-metal implants 1.83
Epigenetic Lanscape and BRD4 Transcriptional Dependency of PAX3-FOXO1 Driven Rhabdomyosarcoma 1.81
PAX3-FOXO1 requires BRD4 to drive oncogene addiction in RMS cells [RNA-seq] 1.81
Large-Scale Atlas of Mutant IDH1-Dependent Chromatin State Reprogramming, Reversibility, and Persistence 1.7
Large-Scale Atlas of Mutant IDH1-Dependent Chromatin State Reprogramming, Reversibility, and Persistence [RNA-seq] 1.7
Analysis of human ES cell differentiation establishes that the dominant isoforms of the lncRNAs RMST and FIRRE are circular 1.69
Genome-Wide DNA Methylation Encodes Cardiac Transcriptional Reprogramming in Human Ischemic Heart Failure [RNA-Seq] 1.65
Genome-Wide DNA Methylation Encodes Cardiac Transcriptional Reprogramming in Human Ischemic Heart Failure [DNA Methylation] 1.65
Gene expression profile of calcified and normal tricuspid aortic valves by RNA sequencing. 1.65
Analysis of MGE Transcriptomes with or without Ctnnb1 knockout in human through RNA Sequencing 1.65
RNA-Seq with and without RNase treatment in PCa cell lines 1.65
The RNA-binding protein RBM47 suppresses metastatic breast cancer progression 1.61
mTOR hyperactivation in Down Syndrome mediates deficits in autophagy induction, autophagosome formation, and mitophagy 1.6
Patient-derived xenograft platform for metastatic melanoma 1.55
FGF2 regulation of gene expression in stable inducible Neurons 1.47
Gene expression profiling study by RNA-seq in PDX model based diffuse type gastric cancers. 1.45
RNA-sequencing of Wnt-dependent and Wnt-independent of Glioblastoma stem cell cultures 1.41
Human pluripotent stem cell-derived brain tumor model uncovered embryonic stem cell signature as a key driver in atypical teratoid/rhabdoid tumor (RNA-Seq) 1.4
EPCR Expression Defines the Most Primitive Subset of Human HSPC and Is Required for Their In Vivo Activity 1.37
Identifying deer antler proliferation and mineralization genes using comparative RNA-seq 1.37
Time series total RNA sequencing of a differentiation of human embryonic stem cells towards trophoblast lineage 1.35
Deep sequencing of transcript levels of human embryonic stem cell derived mesothelium (epithelial and mesenchymal forms) and mesothelium from neonatal mouse E15.5 of the heart, lung, liver and gut and ChIP-seq data of the mesenchymal form of mesothelium 1.34
Transcriptome analysis of eosinophilic and noneosinophilic chronic rhinosinusitis with nasal polyps reveals distinct lncRNA expression profiles 1.34
Gene expression profiles of isogenic single-cell derived clones of BRAF-mutated SK-MEL-5 melanoma cell lines 1.32
Robust generation of honemogeneous midbrain organoids with in vivo–like cellular composition facilitates neurotoxin-based Parkinson’s disease modeling 1.31
RNA-sequencing of human tendon after injury 1.3
H3.3K27M cooperates with p53 loss and Pdgfra gain in mouse embryonic neural progenitor cells to induce invasive high-grade gliomas [Human RNA-Seq] 1.25
H3.3K27M cooperates with p53 loss and Pdgfra gain in mouse embryonic neural progenitor cells to induce invasive high-grade gliomas 1.25
Profiling gene expression changes in ovarian cancer cells seeded on 3D organotypic culture of omentum 1.24
The histone H3.3K36M mutation reprograms the epigenome of chondroblastomas 1.22
Pervasive transcription read-through promotes aberrant expression of oncogenes and RNA chimeras in renal carcinoma 1.2
RNA-Seq Analysis in purified iPS cell-derived neuronal samples 1.19
RNA-Seq data of NCI-H82 cells expressing a Dox-On pRB (pTripZ RB1) grown in the presence or absence of DOX and then treated with vehicle or AZD2811. 1.14
Transcriptome analysis of diverse cell types infected with human cytomegalovirus 1.14
Ex vivo expanded human 3D Nephrospheres engraft long term and repair chronic renal injury in mice 1.12
AQP5-Expressing Cells Serve as Stem Cells and Cancer Origins in the Distal Stomach 1.11
Gastrointestinal Stromal Tumor Enhancers Support a Transcription Factor Network Predictive of Clinical Outcome 1.09
Gastrointestinal Stromal Tumor Enhancers Support a Transcription Factor Network Predictive of Clinical Outcome 1.09
Robust prediction of response to immune checkpoint blockade therapy in metastatic melanoma 1.05
The serine hydroxymethyltransferase-2 (SHMT2) initiates lymphoma development through epigenetic tumor suppressor silencing. 1.05
Gene expression profiling in follicular lymphoma (FL) samples and paired transformed follicular lymphoma (tFL) (n=6 samples) 1.05
Transcriptome analysis reveals differential splicing events in IPF lung tissue 1.05
Comparative analysis of WT and ZEB1 KO cells in different stages during differentiation 1.0
RNA-seq in endometrial stromal tumors 0.98
Truncation of LOC100288798 (SLC38A4-AS) lncRNA in human haploid KBM7 cell line 0.95
Positively selected enhancer elements endow tumor cells with metastatic competence 0.94
RNA-Seq of Breast and Ovarian Cancer Cell Lines 0.9
Alternative classification of glioblastoma based on BUB1B-inhibition sensitivity 0.89
Transcriptomic Analysis of Endothelial Cells from Fibrovascular Membranes in Proliferative Diabetic Retinopathy 0.88
The transcriptome of Kawasaki Disease arteritis 0.87
RNA-Seq and expression data from human adipose tissue 0.86
Tissue-specific RNA-seq in human evoked inflammation identifies novel blood and adipose lincRNA signatures of cardio-metabolic diseases 0.86
Single-cell survey of human lymphatics unveils marked endothelial cell heterogeneity and mechanisms of homing for neutrophils 0.86
CUREfast: Accelerating research with families 0.85
Engineering Patient-Specific Tissue Implants 0.82
A faithful in vivo model of human MLL-AF4 proB acute lymphoblastic leukemia 0.78
RNA-Seq of LRRK2 G2019S Parkinson’s iPSC-derived astrocytes 0.77
hNSCs siRNA NOVA2 0.76
Zika Virus Has Oncolytic Activity against Glioblastoma Stem Cells 0.75
Global epigenomic reconfiguration during mammalian brain development 0.7
Identification of expressed and conserved human non-coding RNAs 0.67
Genome-wide expression analysis of young, senescent and p38MAPK-inhibitited senescent human fibroblasts. 0.67
Stranded RNA-seq were performed on total RNA following ribosomal RNAs depletion (Ribo-zero removal kit, illumina) for 3 brain , 8 IDHwt and 5 IDHmut glioma samples. 0.67
Transcriptional dependencies in diffuse intrinsic pontine glioma 0.64
Developmental origins define epigenomic differences between subcutaneous and visceral adipocytes [RNA-Seq] 0.62
The Glioma-Infiltrating T Cell Receptor Repertoire 0.62
Effect of low-dose sorafenib and alkylating agents in inflammation and angiogenesis in breast cancer 0.61
FGF2 induces migration of human bone marrow stromal cells by increasing core-fucosylations on N-glycans of integrins 0.6
Leucegene: ALL sequencing 0.56
Enhancement of direct reprogramming from fibroblasts to epithelial lineages by OVOL2-induced mesenchymal-to-epithelial transition [CAGE] 0.53
Enhancement of direct reprogramming from fibroblasts to epithelial lineages by OVOL2-induced mesenchymal-to-epithelial transition 0.53
RNA-Seq identifies condition-specific biological signatures of ischemia-reperfusion injury in the human kidney 0.51
Effects of darunavir upon gene expression in kidney tubular cells after transduction with HIV or EGFP-control lentivirus 0.46
Human T-cell lymphoblastic lymphoma samples and control thymuses 0.44
RNA-Seq in human T-cell lymphoblastic lymphoma samples and control thymuses 0.44
Loss of Nuclear TDP-43 Is Associated with Decondensation of LINE Retrotransposons 0.44
Loss of Nuclear TDP-43 Is Associated with Decondensation of LINE Retrotransposons [RNA-Seq] 0.44
Small molecule inhibition of ERK dimerization prevents tumorigenesis by Ras-ERK pathway oncogenes 0.43
Long-term expandable SOX9+ chondrogenic ectomesenchymal cells from human pluripotent stem cells 0.41
Transcriptome sequencing reveals aberrant alternative splicing in Huntington's disease 0.38
Diarrhoeal mechanisms of the Campylobacter jejuni enteritis 0.34
Genome-wide expression analysis of human hTert immortalized fibroblasts after downregulation of MCM2 & MCM7 0.32
RNA-Sequencing shows novel transcriptomic signatures in failing and non-failing human heart 0.29
Expression patterns in chronic thromboembolic pulmonary hypertension 0.26
Increased Neanderthal ancestry in genomic regions associated with lipid catabolism in contemporary Europeans 0.25
RNA sequencing of lesional and nonlesional skin from patients with atopic dermatitis 0.24
6mer seed toxicity in tumour suppressive microRNAs 0.21
Expression profiles of the four human major ectodermal lineages 0.19
RNA-seq expression data from FL-HSPCs after HOXA7 knockdown 0.19
RNA-sequencing analysis of glucose and acetate regulated transcripts in glioblastoma cells 0.17
The bromodomain protein BRD4 regulates splicing during heat shock 0.17
Transcriptomic analysis of frontal fibrosing alopecia 0.17
Hsa-miR-139-5p/HNRNPF axis modulates gene-transcripts balance in thyroid cancer cells 0.15
Differentially Expressed Genes for Atrial Fibrillation Identified using RNA Sequencing from Paired Human Left and Right Atrial Appendages. 0.15
The MEF2B Regulatory Network - RNA-seq data 0.14
The MEF2B Regulatory Network 0.14
Toxoplasma controls host cyclin E expression through the use of a novel MYR1-dependent effector protein, HCE1 0.1
WNT signaling memory is required for ACTIVIN to function as a morphogen 0.07
RNA expression profiles comparing primary and omental ovarian carcinoma samples 0.04
RNA-seq and small RNA-seq from WT and ADAR1 knockdown H9 lines and their differentiation to specific types of neurons 0.03
Next Generation Sequencing Facilitates Comparisons of Control and Schizophrenia-Patient derived hiPSC-derived NPCs 0.03
Serotonin-induced hyperactivity in SSRI-resistant major depressive disorder patient-derived neurons 0.02
Gene expression in skeletal muscle in older individuals subject to ten days of complete bed rest. 0.01


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation